Monona, WI, United States of America

Julia Hegge



Average Co-Inventor Count = 4.5

ph-index = 4

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2006-2010

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations by Julia Hegge

Introduction

Julia Hegge is an accomplished inventor based in Monona, Wisconsin. She has made significant contributions to the field of biomedical engineering, particularly in the delivery of therapeutic agents to cells. With a total of nine patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents is a method for the intravenous delivery of polynucleotides to cells in mammalian limbs. This innovative approach involves injecting polynucleotides into a distal vein of a limb that is temporarily occluded. The method allows for effective delivery by facilitating the rapid injection of a sufficient volume to enable the solution to extravasate into surrounding tissue. Another notable patent describes a process for delivering small interfering RNA (siRNA) to cardiac muscle tissue. This process involves introducing a polynucleotide composition into a blood vessel and increasing the permeability of the vessel to the polynucleotide, which can inhibit gene expression in cardiac cells.

Career Highlights

Julia has worked with prominent companies in the biotechnology sector, including Roche Madison Inc. and Mirus Bio Corporation. Her experience in these organizations has contributed to her expertise in developing innovative delivery methods for therapeutic agents.

Collaborations

Throughout her career, Julia has collaborated with notable professionals in her field, including Jon Asher Wolff and James E. Hagstrom. These collaborations have further enriched her research and development efforts.

Conclusion

Julia Hegge's contributions to the field of biomedical engineering through her innovative patents demonstrate her commitment to advancing medical science. Her work in polynucleotide delivery methods holds promise for improving therapeutic outcomes in various medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…